How Do Dermal Fillers Work?
Dermal fillers work by two different mechanisms, and the difference is the single most useful thing to understand about them. Some fillers work mechanically — they occupy space and hold water, so the tissue above them is lifted. Others work biologically — they are designed to provoke the body into producing its own collagen, and the volume that appears weeks later is the patient's own tissue. A third group does both at once.
This changes what "when will I see the result" and "how long will it last" actually mean for each material, and it explains why two products with similar descriptions behave nothing alike. The question "how do dermal fillers work" is really two questions, one mechanical and one biological, and answering them separately is what makes each material's behaviour predictable. This page covers the mechanism at the tissue level — how the gel integrates, what cross-linking does, the degradation pathway for each family and how placement depth changes the outcome. It is written for practitioners, clinic owners and buyers. For the classification of the materials themselves, see types of dermal fillers; for the raw-material composition, see what dermal fillers are made of.
How Do Dermal Fillers Work? The Two Mechanisms Compared
Every absorbable filler acts through one, or both, of the following. The distinction determines onset, duration and how predictable the final result is.
| Property | Mechanical (volume displacement) | Biological (collagen biostimulation) |
|---|---|---|
| What provides the result | The injected material itself, plus the water it binds | New collagen laid down by the patient's own tissue |
| Onset | Immediate — visible at the end of the appointment | Gradual — weeks, building over a course of sessions |
| Main materials | Hyaluronic acid | Poly-L-lactic acid |
| Both at once | Calcium hydroxylapatite — carrier gives immediate volume, microspheres then stimulate collagen | — |
| Reversible | Yes — hyaluronidase dissolves HA | No — the deposited collagen is the patient's own tissue |
| Result depends on | Product rheology and placement — largely predictable from the spec | Product plus the individual patient's tissue response |
That last row is the one buyers and clinic owners most often overlook. A mechanical filler's outcome is defined by the specification on the data sheet. A biological filler's outcome also depends on the patient — which is why two patients receiving the same protocol can end up with visibly different results, and why a supplier's consistency across batches matters even more for the biostimulator category.
Mechanism 1: Volume Displacement and Water Binding
Understanding "how do dermal fillers work" begins with the fact that hyaluronic acid does two things at once when it is placed in tissue.
First, it occupies space. The cross-linked gel is injected into a specific plane and physically displaces the tissue around it, so a fold that was tethered inward is lifted outward. This part of the effect is mechanical and immediate — it is present before the patient leaves the room.
Second, it binds water. Hyaluronic acid is strongly hydrophilic: it attracts and holds water molecules within its network. This is the property that makes HA useful for skin hydration as well as for volume, and it is also why a freshly treated area can look slightly fuller for the first few days than it will once initial swelling settles. The water-binding behaviour is not a side effect — for non-cross-linked HA used at a superficial level, it is the entire mechanism.

What keeps the gel in place rather than spreading away is its elastic modulus, or G-prime — the same property that determines which layer a filler suits. A gel with high G-prime resists being deformed by the tissue pressing down on it, so it maintains projection. A gel with low G-prime flows into the surrounding plane instead. The types of dermal fillers page sets out the G-prime classes; the point here is that G-prime is a mechanical property acting on a mechanical mechanism.
Mechanism 2: Collagen Biostimulation
Biostimulators contain particles that the body treats as a scaffold. Instead of the injected material providing the volume, the material triggers a wound-healing-type response in which the patient's own fibroblasts deposit new collagen around the particles. As the particles are gradually metabolised, the collagen that formed around them remains.
Two practical consequences follow. The first is delayed onset: there is little immediate correction, and the result appears over weeks as collagen accumulates. The second is that the effect is usually built through a course rather than a single appointment. This pattern is well documented for PLLA — clinical guidance describes patients typically needing around three treatments spaced about a month apart, with results appearing gradually over the following months.

Calcium hydroxylapatite runs both mechanisms in sequence. The gel carrier delivers immediate volume, exactly as HA does; the CaHA microspheres suspended within it then act as the scaffold for a collagen response. This is why CaHA is described as a dual-effect material, and why its reported duration is longer than HA's even though part of its initial behaviour is identical.

Because the collagen response depends on the tissue, particle characteristics matter more here than in the mechanical category. Particle size distribution determines how evenly the response is distributed; carrier composition determines what happens in the first hours; and the consistency of both across batches determines whether a protocol that worked last month behaves the same way this month. The CaHA range and the PLLA range list the specifications per line.
The numbers behind that point are visible in our own published specification for the HA range: particle size rises and particle count falls as the target layer deepens, from 200,000 gel particles per millilitre at 0.10~0.15 mm in the Fine grade to 5,000 per millilitre at 0.5~1.25 mm in Subskin. The ASPS material guide describes the same principle for the particle-based materials, and notes that polylactic acid has been used as a suture material for more than 40 years — a relevant fact when assessing the polymer's long-term tissue behaviour.
Cross-Linking: How the Gel Resists Breakdown
Left alone, hyaluronic acid is cleared from tissue within days. What extends that to months is cross-linking — chemically bonding the HA chains to one another to form a three-dimensional network that the body's degradation mechanisms cannot dismantle quickly.
| Property | Non-cross-linked HA | Cross-linked HA |
|---|---|---|
| Structure | Free chains in solution | Chains bonded into a network |
| Residence time in tissue | Short — measured in days | Months |
| Primary effect | Hydration and skin quality | Volume, support and lift |
| Can be dissolved with hyaluronidase | Yes | Yes — cross-linking slows but does not prevent enzymatic breakdown |
Degree of cross-linking is therefore one of the most important numbers on a technical data sheet, because it drives both duration and firmness. It is also the parameter most often omitted from marketing material, which is why the composition page treats it as a specification item rather than a claim.
How Each Family Is Eventually Cleared
"Absorbable" does not mean the same thing for every material. Each family leaves the body by a different route, and the route determines both the safety profile and whether an antidote exists.
| Material | Cleared by | End products | Antidote |
|---|---|---|---|
| Hyaluronic acid | Enzymatic breakdown, then normal HA metabolism | Water and simple sugars already present in the body | Hyaluronidase |
| Calcium hydroxylapatite | Gradual dissolution of the microspheres | Calcium and phosphate — constituents of bone | None |
| Poly-L-lactic acid | Hydrolysis of the polymer chain | Lactic acid, then carbon dioxide and water | None |
| PMMA | Not cleared — the microspheres remain | Retained permanently | None |
Hyaluronic acid occupies a category of its own here. It is the only family for which a clinician can actively reverse the result after the fact, and clinical sources describe this capability explicitly: Medical News Today notes that an enzyme can be injected to dissolve filler within a day, and the Cleveland Clinic sets out the same material-by-material position. For a clinic building its first injectable menu, that reversibility is a risk-management property, not merely a convenience.
The Time Course After Injection
This is the section where "how do dermal fillers work" becomes visible to the patient rather than to the formulator. The two mechanisms produce very different timelines, and placed side by side the contrast is the clearest illustration of why the distinction matters.
| Time after injection | Hyaluronic acid (mechanical) | PLLA (biological) |
|---|---|---|
| Immediately | Volume visible; gel occupies the plane and begins binding water | Little visible correction |
| First 1–3 days | Initial swelling settles; the treated area can appear fuller than the final result | Inflammatory response begins around the particles |
| 2–3 weeks | Result is stable and assessable | Effect becoming visible as collagen is deposited |
| 1–3 months | Gradual slow decline begins, depending on cross-linking density | Result consolidating across the treatment course |
| Long term | Typically 6–12 months; a further appointment is usually needed | Typically measured in years; sources give one to three years depending on the indication |
The 1–3 day window deserves a note because it sits behind a great deal of confusion in patient-facing content. Neither family produces its final result on the day of treatment. HA appears larger than the final outcome while initial swelling is present; PLLA appears smaller than the final outcome because the collagen response has not yet happened. The AAD filler FAQ records the same divergence in onset — hyaluronic acid results are immediate, while poly-L-lactic acid onset is measured in weeks.
Why Placement Depth Changes the Outcome
The same product injected into two different planes does not produce the same result, because the mechanical load on the gel changes with depth. Tissue nearer the surface is under less load and moves more freely; tissue in deeper planes carries more weight and requires a product that will not deform under it.
This is why the depth grades exist at all. A superficially formulated product placed deep would be dispersed by the load above it and fail to provide support; a densely cross-linked product placed superficially would be too firm for the plane and can produce visible irregularities. The depth grade table maps the four conventional grades — fine, derm, deep and subskin — to their target layers, and the dermal filler range lists a line for each grade so a clinic can match product to plane rather than using one product everywhere.
Why Fillers Are Not Neuromodulators
Fillers and botulinum toxin injections are frequently discussed together, and their mechanisms are close to opposite.
| Aspect | Dermal filler | Botulinum toxin |
|---|---|---|
| Target | Volume and skin structure | Muscle movement |
| Mechanism | Adds material, or stimulates collagen | Reduces muscle contraction |
| Corrects | Static folds and lost volume | Dynamic lines produced by movement |
| Typical duration | Months to years depending on material | Around 3 to 4 months |
The practical implication is that a fold with both a static and a dynamic component may need both categories, and that neither substitutes for the other. The main dermal filler overview covers the comparison in more detail.
What the Mechanism Means When You Buy
The practical value of understanding how do dermal fillers work is that it converts several vague purchasing criteria into specific, checkable ones. Each row below follows directly from a mechanism described above.
| Mechanism property | What to ask the supplier for |
|---|---|
| G-prime and gel firmness | The technical data sheet value, not a descriptive term such as "strong" or "soft" |
| Cross-linking status and density | Stated on the specification, including whether a linker such as BDDE is used |
| Particle size (CaHA, PLLA) | Size distribution, since it governs how evenly the collagen response is distributed |
| Reconstitution volume (PLLA) | The diluent volume stated per vial, because it changes the concentration |
| Batch consistency | Certificate of analysis per batch — the mechanism depends on the specification being met every time |
A supplier who can only describe the product in marketing language cannot answer any of these. AuroThread manufacturers across all three absorbable families, so the mechanism-specific specification is available per line: see the dermal filler range for HA, the CaHA collection for the dual-mechanism material and the PLLA collection for the biostimulator line. For the wider due-diligence picture, see the complete dermal filler guide.
Sources
The mechanism and durability statements on this page are taken from the following published sources. Links open the original document.
- American Academy of Dermatology — Fillers: FAQs — onset and duration by material, including the delayed onset of poly-L-lactic acid.
- American Society of Plastic Surgeons — Types of Dermal Fillers — particle-based mechanism, polylactic acid history as a suture material, and the treatment course pattern.
- Cleveland Clinic — Dermal Fillers — material duration figures and the reversibility position.
- Medical News Today — Botox and dermal fillers compared — hyaluronidase reversal and the mechanism contrast with neuromodulators.
- US Food and Drug Administration — Dermal Filler Do's and Don'ts — material descriptions and the device classification.
- Healthline — Considering Dermal Fillers — clinically reviewed duration ranges by material.
Frequently asked questions
Select a question to open the answer.
How do dermal fillers work?
Through one of two mechanisms. Mechanical fillers, which are hyaluronic acid based, occupy space and bind water to lift the tissue above them — the effect is immediate. Biological fillers, which include poly-L-lactic acid, act as a scaffold that prompts the patient's own tissue to lay down new collagen, so the effect appears gradually over weeks. Calcium hydroxylapatite does both: a gel carrier for immediate volume and microspheres for a collagen response.
Do dermal fillers add water to the skin?
Hyaluronic acid does. It is strongly hydrophilic and holds water within its network, which is why it works both for volume and for skin hydration. For non-cross-linked HA used superficially, water binding is the entire mechanism rather than a side effect. It is also why a freshly treated area can look slightly fuller in the first few days than it will once initial swelling settles.
How do collagen-stimulating fillers work?
They contain particles the body treats as a scaffold. Fibroblasts deposit new collagen around those particles during a controlled healing response, and as the particles are gradually metabolised the collagen that formed remains. Because the volume comes from the patient's own tissue rather than the injected material, the result builds over weeks and is usually achieved through a course of sessions rather than one appointment.
What does cross-linking do in a dermal filler?
It bonds hyaluronic acid chains into a three-dimensional network, so the body cannot break the gel down within days as it would native HA. Cross-linking is what extends residence time from days to months, and the degree of cross-linking also determines how firm the gel is. It is one of the most important values on a technical data sheet, and one of the most frequently omitted from marketing copy.
Why do results look different a few days after treatment?
Because neither family produces its final result on the day of treatment. With hyaluronic acid, initial swelling makes the area look fuller than the settled outcome, and the result becomes properly assessable at around two to three weeks. With collagen-stimulating fillers the opposite is true: there appears to be little correction at first, and the effect becomes visible as collagen is deposited over the following weeks.
How is hyaluronic acid eventually broken down?
It is broken down enzymatically and then metabolised through the body's normal hyaluronic acid pathways, ending as water and simple sugars that are already present in the body. That same pathway is what makes it reversible: the enzyme hyaluronidase can be injected to accelerate the breakdown deliberately if the result is unsatisfactory. Cross-linking slows this process but does not prevent it.
Why can only some fillers be dissolved?
Because only hyaluronic acid has an enzyme that can break it down on demand. Hyaluronidase is specific to HA, so it has no effect on calcium hydroxylapatite, poly-L-lactic acid or PMMA. For the collagen-stimulating materials, the visible volume is partly the patient's own newly formed collagen, which cannot be dissolved by any injected agent. This is the main structural reason HA dominates first-time formularies.
Does placement depth change how a filler works?
Yes, because the mechanical load on the gel changes with depth. Tissue nearer the surface is under less load and moves freely, while deeper planes carry more weight and require a product that will not deform under it. That is the reason the four depth grades exist: a superficially formulated product placed deep would be dispersed by the load above it, and a densely cross-linked product placed superficially would be too firm for the plane.
Are fillers and Botox the same mechanism?
No — they are close to opposite. Fillers add volume or stimulate collagen to correct static folds and lost volume. Botulinum toxin reduces muscle contraction to soften the dynamic lines produced by movement. They target different tissue, they behave differently over time, and neither substitutes for the other. A fold with both a static and a dynamic component may call for both categories.
Does a biostimulator work if the patient's collagen response is weak?
The response depends partly on the individual, which is the principal difference between a mechanical and a biological mechanism. A mechanical filler's outcome is largely defined by the product specification and its placement; a biological filler's outcome also depends on how that patient's tissue responds. It is why the same protocol can produce visibly different results in two patients, and it is a factor the treating practitioner assesses rather than something the product specification can guarantee.
What should a buyer check on the specification because of the mechanism?
G-prime or gel firmness as a technical value; cross-linking status and density, including whether a linker such as BDDE is used; particle size distribution for calcium hydroxylapatite and poly-L-lactic acid products, since it governs how evenly the collagen response is distributed; the stated reconstitution volume for powder-format products; and a certificate of analysis per batch, because a mechanism that depends on the specification only behaves consistently if the specification is met every time.
Supplying a clinic or building your own filler brand? AuroThread manufactures across hyaluronic acid, calcium hydroxylapatite and poly-L-lactic acid with full documentation and OEM capability. Request wholesale pricing and samples · Browse the dermal filler range
